RxDoctor Payments Data

Scott Commins, MD

Allergy & Immunology · Chapel Hill, NCNPI 1770795486

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $437,919 of the $555,408 with a category attached, or 78.8%. 10 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 48.5% of the total. Among allergy & immunology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$555,408in general payments, 2019–2025

Across 506 payments — averaging $1097.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$269K
  • Genentech USA, Inc.$269K
  • Genentech, Inc.$9K
  • Roche Products Limited$5K
  • Alnylam Pharmaceuticals Inc.$2K
  • AstraZeneca$368
  • plus $657 from 4 others

What the payments were for

  • Consulting fees$32,9296%
  • Speaking & faculty fees$437,91979%
  • Travel & lodging$72,20413%
  • Food & beverage$12,3502%
  • Education$70%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$555,408 in reported general payments places this provider in the 95th percentile of 140 allergy & immunology providers in North Carolina.

See all allergy & immunology providers in North Carolina

Medicare billing

Part B allowed, 2024
$79,448
Medicare patients
120
Services billed
2,126

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XolairOmalizumab49$178,871
Dupixent PenDupilumab12$44,726
Cromolyn Sodium124$27,459
Epinephrine34$6,753
Advair HfaFluticasone Propion/Salmeterol15$5,802
Zafirlukast15$1,521
Hydroxychloroquine Sulfate12$936
Azelastine Hcl12$848
Doxycycline Hyclate13$612
Albuterol Sulfate HfaAlbuterol Sulfate17$554
Prednisone24$264
Montelukast Sodium18$234
Triamcinolone Acetonide11$131

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Genentech, Inc.Xolair$9,487$178,87149 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 140 allergy & immunology providers in North Carolina.

Other allergy & immunology in Chapel Hill

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →